Analystreport

Allena Pharmaceuticals Inc (NASDAQ: ALNA) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $26.00 price target on the stock.

Allena Pharmaceuticals, Inc.  (ALNA) 
Last allena pharmaceuticals, inc. earnings: 3/16 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.allenapharma.com/investor-relations